Company profile

GlyProVac company profile

GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2018-01-01

Headquarters

Headquarters
Denmark, Odense, Syddanmark
Postal code
5220
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $467K / 2024-02-29
Investors
1
Lead investors
1

Founders and investors

Lead investors

CARB-X

Investors

CARB-X

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.